Decoding microbial-Aryl Hydrocarbon Receptor interactions at the skin barrier interface
解码皮肤屏障界面处的微生物-芳基烃受体相互作用
基本信息
- 批准号:10689803
- 负责人:
- 金额:$ 9.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcneAdhesionsAdvisory CommitteesAir PollutantsAllergensAryl Hydrocarbon ReceptorAtopic DermatitisAttenuatedBioinformaticsCommunitiesComplexCoupledData SetDehydrationDiseaseEcologyEcosystemEnvironmentEnvironmental ExposureEpidermisEpitheliumFlowersFunctional disorderGenetic TranscriptionGerm-FreeGnotobioticGoalsHomeHomeostasisHumanImmuneIn VitroInfectionInflammationKnock-outLigand BindingLigandsMass Spectrum AnalysisMediatingMentorsMetagenomicsModelingMultiomic DataMusNamesPathway interactionsPatientsPennsylvaniaPermeabilityPhasePrecision therapeuticsPremature aging syndromeProbioticsPsoriasisReceptor SignalingRegulationResearchResourcesRoleRosaceaSignal TransductionSkinSkin repairSystemSystems BiologyTestingTherapeuticTight JunctionsTrainingTryptophanTryptophan Metabolism PathwayUV inducedUltraviolet RaysUniversitiesXenobioticsaryl hydrocarbon receptor ligandcareercell typecommensal microbesdesignefficacy testingepithelial repairhigh throughput screeninghost microbiomehost microbiotaimprovedinhibitormembermetabolomicsmetagenomic sequencingmicrobialmicrobial communitymicrobiomemicrobiotamouse modelmultiple omicsnovel therapeuticspathogenpollutantpreventrepairedresponsesensorskillsskin barrierskin disorderskin microbiometargeted treatmenttherapeutic evaluationtooltranscription factortranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
An effective epidermal permeability barrier (EPB) protects the skin from dehydration, inflammation, premature
aging, environmental exposure, and infection. Epidermal barrier dysfunction is an important feature of atopic
dermatitis, as well as numerous skin diseases including psoriasis, acne, and rosacea. A fundamental and
holistic understanding of mechanisms regulating homeostatic barrier function is essential to effectively prevent
and manage barrier abnormalities. The EPB function resides in the skin epidermis, which is home to diverse
microbial communities. The microbiome is recognized as a functional unit of the skin barrier. The skin
ecosystem is continuously challenged by the external exposome that includes ultraviolet radiation (UVR), air
pollutants and allergens. Critical for the barrier defense and homeostasis are xenobiotic sensors that recognize
external signals and help identify beneficial (e.g., commensal microbes) from harmful (e.g., pollutants,
pathogens) xenobiotics to regulate barrier defenses. Recently, I have demonstrated that commensal microbes
regulate epidermal differentiation and barrier permeability of the skin by activating xenobiotic sensor, the aryl
hydrocarbon receptor (AHR). However, the mechanisms by which commensal microbes regulate EPB through
AHR under homeostasis, and in presence of environmental insults such as UVR are unexplored. The central
hypothesis of this proposal is that tuning of epithelial responses by modulating AHR-commensal interactions
can alter barrier permeability. This project utilizes ‘multi-omics’ approaches by integrating transcriptomics,
metagenomics, and metabolomics to understand host-microbiota interactions in skin barrier repair. In Aim 1, I
will identify microbial signals from a synthetic commensal community that can activate AHR. These studies will
lead to identification of microbial ligands that can be used to target AHR in barrier diseases. In Aim 2, I will test
contributions of commensal microbiome in protecting against UV-induced barrier damage and use multiomics
approaches to characterize microbiome-host-UV interactome in the context of AHR signaling. These studies
will provide a framework to generate therapies that leverage understanding of environmental-host-microbiome
interactions. During the K99 phase, I will be trained in metabolomics to identify microbial metabolites. I will
receive advanced training in bioinformatics and systems biology approaches that focus on integrating multiple
omics datasets. The outstanding training environment at the University of Pennsylvania coupled with the
excellent advisory committee I have assembled, will greatly facilitate my research during the mentored phase
as well as launch my career with the skills necessary for understanding the role of the microbiome-host-
environment interactome in regulating skin barrier repair.
项目摘要
有效的表皮渗透屏障(EPB)保护皮肤免受脱水,炎症,过早老化,
老化、环境暴露和感染。表皮屏障功能障碍是特应性皮炎的重要特征,
皮炎以及包括牛皮癣、痤疮和红斑痤疮在内的多种皮肤病。了根本遵循和
全面了解调节内稳态屏障功能的机制对于有效预防
并控制屏障异常EPB功能位于皮肤表皮,这是各种
微生物群落微生物组被认为是皮肤屏障的功能单位。皮肤
生态系统不断受到外部干扰的挑战,包括紫外线辐射(UVR),空气
污染物和过敏原。对于屏障防御和体内平衡至关重要的是异生素传感器,
外部信号并帮助识别有益的(例如,微生物)从有害的(例如,污染物,
病原体)外源性物质来调节屏障防御。最近,我证明了肠道微生物
调节表皮分化和皮肤的屏障渗透性,通过激活异生素传感器,芳基
碳氢化合物受体(AHR)。然而,肠道微生物调节EPB的机制,
AHR下的稳态,并在存在环境损伤,如紫外线辐射是未经探讨的。中央
该建议假设是通过调节AHR-上皮细胞相互作用来调节上皮细胞反应
可以改变屏障渗透性。该项目通过整合转录组学,
宏基因组学和代谢组学,以了解皮肤屏障修复中的宿主-微生物群相互作用。在目标1中,
将识别来自合成共生群落的可以激活AHR的微生物信号。这些研究将
从而鉴定出可用于靶向屏障疾病中的AHR的微生物配体。在目标2中,我将测试
肠道微生物组在保护免受紫外线诱导的屏障损伤和使用多组学方面的贡献
在AHR信号传导的背景下表征微生物组-宿主-UV相互作用组的方法。这些研究
将提供一个框架,以产生利用对环境-宿主-微生物组的理解的疗法
交互.在K99阶段,我将接受代谢组学培训,以识别微生物代谢物。我会
接受生物信息学和系统生物学方法的高级培训,重点是整合多个
组学数据集。宾夕法尼亚大学出色的培训环境,
我组建了一个优秀的咨询委员会,这将极大地促进我在指导阶段的研究
同时,我也开始了我的职业生涯,掌握了理解微生物宿主的作用所必需的技能,
环境相互作用组在调节皮肤屏障修复中的作用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cutibacterium acnes evolution: One pore at a time.
痤疮皮肤杆菌进化:一次一个毛孔。
- DOI:10.1016/j.chom.2022.01.007
- 发表时间:2022
- 期刊:
- 影响因子:30.3
- 作者:Flowers,Laurice;Campbell,Amy;Uberoi,Aayushi
- 通讯作者:Uberoi,Aayushi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AAYUSHI UBEROI其他文献
AAYUSHI UBEROI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AAYUSHI UBEROI', 18)}}的其他基金
Decoding microbial-Aryl Hydrocarbon Receptor interactions at the skin barrier interface
解码皮肤屏障界面处的微生物-芳基烃受体相互作用
- 批准号:
10507321 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 9.06万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 9.06万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 9.06万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 9.06万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 9.06万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 9.06万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 9.06万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:














{{item.name}}会员




